Structure‐antigenicity of the V3 region of SIVmac envelope glycoprotein
Abstract
The objective of this study was to analyze the immunogenicity and antigenicity of the V3 domain (Cys313-Cys346) of the external envelope glycoprotein gp125 of SIVmac251. The corresponding peptide was synthesized and characterized as linear and cyclic peptides. Our results showed that this region, as for HIV-1, contained an immunodominant epitope. The antigenicity was similar for the linear and cyclic peptides when tested against a panel of 15 sera from SIV infected macaques. Similarly, both peptide structures presented similar immunogenicity as shown by the characterization of the anti-peptide antibodies produced in rabbits against the cyclic and linear forms. But, unexpectedly, the antibodies produced against linear peptides recognized with a relatively higher intensity the native envelope gp140 than those produced against the cyclic structure. Furthermore, we showed that these antibodies recognized better the deglycosylated form of the glycoprotein. But, in contrast to the neutralizing activity obtained with anti-V3 peptides from HIV-1, no antiviral activity was obtained with antibodies generated against linear or cyclic SIVmac V3 peptides.
Related Papers
- → Tuberculosis subunit vaccine design: The conflict of antigenicity and immunogenicity(2007)45 cited
- → Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats(2020)12 cited
- Reduction of the antigenicity and immunogenicity of xenografts by a new cross-linking reagent.(1989)
- ANTIGENICITY AND IMMUNOGENICITY OF LEPTOSPIRES GROWN IN CHEMICALLY CHARACTERIZED MEDIUM.(1964)
- → Influence of helical organization on immunogenicity and antigenicity of synthetic peptides(1988)30 cited